- AMLONOR-5
- each uncoated tablet contains Amlodipine Besylates BP eq.to Amlodipine 5mg
|
Uses: Indicated in hypertension, angina including chronic stable and vasospastic types |
10 Tab |
- AMLONOR-A
- each uncoated tablet contains Amlodipine Besylates BP eq.to Amlodipine 5mg, Atenolol IP 50mg
|
3 Tab |
- ATVINOR-10
- each film coated tablet contains Atorvastatin calcium eq. to Atorvastatin 10mg
|
Uses: Indicated in primary hypercholesterolaemia, heterozygous familial hypercholesterolaemina, homozygous familial hyepcholesterolaemao or combined hyperlipidaemia. |
10 Tab |
- ATVINOR-20
- each film coated tablet contains Atorvastatin calcium eq. to Atorvastatin 20mg
|
10 Tab |
- ENORPRIL-2.5
- each uncoated tablet contains Enarpril Maleate IP 2.5mg
|
Uses: Indicated in all grades of essential hypertension & renovascular hypertension. Adjunct in congestive heart failure. |
10 Tab |
- ENORPRIL-5
- each uncoated tablet contains Enarpril Maleate IP 5mg
|
30 ml |
- GLIMPINOR-1
- Each uncoated tablet contains Glimeperide USP 1mg
|
Uses: Indicated in non-insulin dependent diabetes. |
10 Tab |
- GLYNOR-MF
- each uncoated tablet contains Glipezide BP 5mg, Metformin HCL IP 500mg
|
10 Tab |
- LIPRINOR-2.5
- each Uncoated tablet contains Lisionopil (dihydrate) USP eq. to lisinopril 2.5mg
|
Uses: Indicated in all grades of hypertension, hypertension complicated by diabetes mellitus, gout, asthama & mental derpession. Congestive cardiac failure. |
10 Tab |
- LIPRINOR-5
- each uncoated tablet contains Lisinopril (dihydrate) USP eq. to Lisinopril 5mg
|
10 Tab |
- LIPRINOR-10
- each uncoated tablet contains Lisinopril (dihydrate) USP eq. to Lisinopril 10mg
|
10 Tab |
- LOSTINOR-25
- each film coated tablet contains Losartan Potassium USP 25mg
|
Uses: Indicated in mild to moderate hypertension alone or in combination with other hypertensives. |
10 Tab |
- LOSTINOR-50
- each film coated tablet contains Losartan Potassium USP 50mg
|
10 Tab |
- MEFNOR-250
- each uncoated tablet contains Metformin HCL IP 250mg
|
Uses: Indicated in maturity onset(non-insulin dependent) obese diabetics, in whom diet alone has failed. Very unstable juvenile or maturity onset diabetics, where a comibination insulin and metformin is beneficial. In those diabetics where sulphonylureas and metformin, when given alone fail but a combination works. |
10 Tab |
- MEFNOR-500
- each uncoated tablet contains Metformin HCL IP 500mg
|
10 Tab |
- NORGLIC-40
- each uncoated tablet contains Gliclazide BP 40mg
|
Uses: Indicated in non insulin dependent diabetes melitus; diabetes with or without obesity in adults, diabetes in the elderly, diabetes with vascular complications. |
10 Tab |
- NORGLIC-80
- each uncoated tablet contains Gliclazide BP 80mg
|
10 Tab |
- NORGLIC-MF
- each uncoated tablet contains Gliclazide BP 80mg. Metformin HCL IP 500mg
|
10 Tab |
- RAMINOR-2.5
- each uncoated tablet contains Ramipril BP 2.5mg
|
Uses: Indicated in hypertension and cardiac failure. |
10 Cap |
- RAMINOR-5
- each uncoated tablet contains Ramipril BP 5mg
|
10 Tab |
- ROLITON-M
- each film coated tablet contains Rosiglitazone maleater eq. to Rosiglitazone 2mg, Metforming hydrochloride IP 500mg
|
Uses: Used in management of type 2 diabetese mellitus as monotherapy or combination therapy. |
10 Tab |
- ROLITON-MF
- each film coated tablet contains Rosiglitazone maleater eq. to Rosiglitazone 4mg, Metforming hydrochloride IP 500mg
|
10 Tab |
|
